13th Post-ECTRIMS Meeting: review of the new developments presented at the 2020 ECTRIMS Congress (I)
Por:
Fernández O, Montalban X, Aladro Y, Alonso A, Arroyo R, Calles C, Castillo-Triviño T, Comabella M, Costa-Frossard L, Forero L, Ginestal R, Landete L, Llaneza M, Llufriu S, Martínez-Ginés ML, Meca-Lallana J, Mendibe M, Oreja-Guevara C, Oterino A, Prieto JM, Ramió-Torrentà L, Romero-Pinel L, Téllez N and Rodríguez-Antigüedad A
Publicada:
1 jun 2021
Resumen:
Introduction. For more than a decade, following the ECTRIMS Congress, the Post-ECTRIMS Meeting has been held in Spain, where neurologists with expertise in multiple sclerosis (MS) from all over the country meet to review the most relevant latest developments presented at the ECTRIMS congress (on this occasion held together with ACTRIMS).
Aim. This article, published in two parts, summarises the presentations that took place at the Post-ECTRIMS Meeting, held online on 16 and 17 October 2020.
Development. This first part includes the latest results regarding the impact of the environment and lifestyle on risk of MS and its clinical course, and the role of epigenetics and genetic factors on these processes. Findings from preclinical and clinical research on the lymphocyte subtypes identified and the involvement of lymphoid follicles and meningeal involvement in the disease are discussed. Changes in brain structure are addressed at the microscopic and macroscopic levels, including results from high-resolution imaging techniques. The latest advances on biomarkers for the diagnosis and prognosis of MS, and on the involvement of the microbiome in these patients are also reported. Finally, results from patient registries on the impact of COVID-19 in MS patients are outlined.
Conclusions. There have been new data on MS risk factors, the impact of MS at the cellular and structural level, the role of the microbiome in the disease, biomarkers, and the relationship between COVID-19 and MS.
Filiaciones:
Fernández O:
Hospital Regional Universitario de Málaga, Málaga, España
Montalban X:
Hospital Universitario Vall d'Hebron-CEMCAT, Barcelona, España
Aladro Y:
Hospital Universitario de Getafe, 28905 Getafe, España
Alonso A:
Hospital Regional Universitario de Málaga, Málaga, España
Arroyo R:
Hospital Universitario Quirónsalud, Madrid, España
Calles C:
Hospital Universitari Son Espases, Palma de Mallorca, España
Castillo-Triviño T:
Hospital Universitario Donostia, San Sebastián, España
Comabella M:
Hospital Universitario Vall d'Hebron-CEMCAT, Barcelona, España
Costa-Frossard L:
Hospital Universitario Ramón y Cajal, Madrid, España
Forero L:
Hospital Universitario Puerta del Mar, 11009 Cádiz, España
Ginestal R:
Hospital Universitario Clínico de Madrid, Madrid, España
:
Hospital Universitario Doctor Peset, Valencia, España
Llaneza M:
Complejo Hospitalario Universitario de Ferrol, Ferrol, España
Llufriu S:
Hospital Clínic de Barcelona, 08036 Barcelona, España
Martínez-Ginés ML:
Hospital General Universitario Gregorio Marañón, Madrid, España
Meca-Lallana J:
Hospital Clínico Universitario Virgen de la Arrixaca. IMIB-Arrixaca, Murcia, España
Mendibe M:
Hospital Universitario de Cruces, Bilbao, España
Oreja-Guevara C:
Hospital Clínico San Carlos, 28040 Madrid, España
Oterino A:
Hospital Universitario Central de Asturias, Oviedo, España
Prieto JM:
Complejo Hospitalario Universitario de Santiago de Compostela, 15706 Santiago de Compostela, España
Ramió-Torrentà L:
Hospital Universitari Dr. Josep Trueta, 17007 Girona, España
Hospital de Santa Caterina-IDIBGI, Salt, España
Romero-Pinel L:
Hospital Universitario de Bellvitge , Hospitalet de Ll., España
Téllez N:
Hospital Clínico Universitario de Valladolid, Valladolid, España
Rodríguez-Antigüedad A:
Hospital Universitario de Cruces, Bilbao, España
|